# Clinical Trial of the Dual Vector Base Editor for the Treatment of the CHD3-R1025W Mutation

> **NCT06860672** · EARLY_PHASE1 · RECRUITING · sponsor: **Yongguo Yu** · enrollment: 1 (estimated)

## Conditions studied

- Developmental Delay Disorder
- Intellectual Disability
- Rare Diseases

## Interventions

- **GENETIC:** Dual vector DNA base editor

## Key facts

- **NCT ID:** NCT06860672
- **Lead sponsor:** Yongguo Yu
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-19
- **Primary completion:** 2025-04
- **Final completion:** 2025-09
- **Target enrollment:** 1 (ESTIMATED)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06860672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06860672, "Clinical Trial of the Dual Vector Base Editor for the Treatment of the CHD3-R1025W Mutation". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06860672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*